DSUVIA Drug Patent Profile
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Which patents cover Dsuvia, and what generic alternatives are available?
Dsuvia is a drug marketed by Acelrx Pharms and is included in one NDA. There are eighteen patents protecting this drug.
This drug has ninety-two patent family members in nineteen countries.
The generic ingredient in DSUVIA is sufentanil citrate. There are nine drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the sufentanil citrate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Dsuvia
A generic version of DSUVIA was approved as sufentanil citrate by HIKMA on December 15th, 1995.
Summary for DSUVIA
| International Patents: | 92 |
| US Patents: | 18 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 22 |
| Clinical Trials: | 3 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for DSUVIA |
| What excipients (inactive ingredients) are in DSUVIA? | DSUVIA excipients list |
| DailyMed Link: | DSUVIA at DailyMed |
Recent Clinical Trials for DSUVIA
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Frank Guyette | Phase 3 |
| United States Department of Defense | Phase 3 |
| Montefiore Medical Center | Phase 4 |
Pharmacology for DSUVIA
| Drug Class | Opioid Agonist |
| Mechanism of Action | Full Opioid Agonists |
Anatomical Therapeutic Chemical (ATC) Classes for DSUVIA
US Patents and Regulatory Information for DSUVIA
DSUVIA is protected by eighteen US patents.
Patents protecting DSUVIA
Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: TREATMENT OF ACUTE PAIN
Small-volume oral transmucosal dosage forms
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: TREATMENT OF ACUTE PAIN
Storage and dispensing devices for administration of oral transmucosal dosage forms
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Small-volume oral transmucosal dosage forms
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: TREATMENT OF ACUTE PAIN
Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: TREATMENT OF ACUTE PAIN
Small-volume oral transmucosal dosage
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Bioadhesive drug formulations for oral transmucosal delivery
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Bioadhesive drug formulations for oral transmucosal delivery
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: TREATMENT OF ACUTE PAIN
Storage and dispensing devices for administration of oral transmucosal dosage forms
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: TREATMENT OF ACUTE PAIN
Small-volume oral transmucosal dosage forms
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: TREATMENT OF ACUTE PAIN
Bioadhesive drug formulations for oral transmucosal delivery
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: TREATMENT OF ACUTE PAIN
Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: TREATMENT OF ACUTE PAIN
Sufentanil solid dosage forms comprising oxygen scavengers and methods of using the same
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: TREATMENT OF ACUTE PAIN
Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Acelrx Pharms | DSUVIA | sufentanil citrate | TABLET;SUBLINGUAL | 209128-001 | Nov 2, 2018 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Acelrx Pharms | DSUVIA | sufentanil citrate | TABLET;SUBLINGUAL | 209128-001 | Nov 2, 2018 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| Acelrx Pharms | DSUVIA | sufentanil citrate | TABLET;SUBLINGUAL | 209128-001 | Nov 2, 2018 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| Acelrx Pharms | DSUVIA | sufentanil citrate | TABLET;SUBLINGUAL | 209128-001 | Nov 2, 2018 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| Acelrx Pharms | DSUVIA | sufentanil citrate | TABLET;SUBLINGUAL | 209128-001 | Nov 2, 2018 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for DSUVIA
See the table below for patents covering DSUVIA around the world.
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| South Korea | 20080090505 | DRUG STORAGE AND DISPENSING DEVICES AND SYSTEMS COMPRISING THE SAME | ⤷ Try a Trial |
| Canada | 2673856 | FORMES DOSIFIEES DE PETIT VOLUME DE MEDICAMENT CONTENANT DU SUFENTANIL S'ADMINISTRANT PAR VOIE TRANS-MUQUEUSE ORALE POUR LE TRAITEMENT DE LA DOULEUR (SMALL VOLUME ORAL TRANSMUCOSAL DOSAGE FORMS CONTAINING SUFENTANIL FOR TREATMENT OF PAIN) | ⤷ Try a Trial |
| Japan | 2009526553 | ⤷ Try a Trial | |
| South Korea | 101451451 | ⤷ Try a Trial | |
| South Korea | 101497887 | ⤷ Try a Trial | |
| >Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for DSUVIA
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 2114383 | CR 2016 00007 | Denmark | ⤷ Try a Trial | PRODUCT NAME: SUFENTANIL; REG. NO/DATE: EU/1/15/1042/001-006 20150922 |
| 2114383 | 300797 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: SUFENTANIL, DESGEWENST IN DE VORM VAN SUFENTANILCITRAAT; REGISTRATION NO/DATE: EU/1/15/1042 20150922 |
| 2114383 | SPC/GB16/004 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: SUFENTANIL; REGISTERED: UK EU/1/15/1042 20150922 |
| 2114383 | 122016000023 | Germany | ⤷ Try a Trial | PRODUCT NAME: SUFENTANIL, WAHLWEISE IN FORM VON SUFENTANILCITRAT; REGISTRATION NO/DATE: EU/1/15/1042 20150918 |
| 2114383 | CA 2016 00007 | Denmark | ⤷ Try a Trial | PRODUCT NAME: SUFENTANIL, HERUNDER SUFENTANIL SOM CITRAT; REG. NO/DATE: EU/1/15/1042/001-006 20150922 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2023 - 2024
NCE-1 Patent Challenge Dates 2023 - 2024
DrugChatter - AI-based answers to questions about drugs
RxJam - Trigger-based marketing for life sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2023, www.DrugPatentWatch.com.
Follow DrugPatentWatch:
